Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MARS2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA557328
Description
Immunogen sequence: LLNSELADAL GGLLNRCTAK RINPSETYPA FCTTCFPSEP GLVGPSVRAQ AEDYALVSAV ATLPKQVADH YDNFRIYKAL EAVSSCVRQT NG Highest antigen sequence identity to the following orthologs: Mouse - 84%, Rat - 84%.
Methionine-tRNA ligase (EC 6.1.1.10) catalyzes the chemical reaction: ATP + L-methionine + tRNAMet <--> AMP + diphosphate + L-methionyl-tRNAMetThe 3 substrates of this enzyme are ATP, L-methionine, and tRNA(Met), whereas its 3 products are AMP, diphosphate, and L-methionyl-tRNA(Met).This enzyme participates in 3 metabolic pathways: methionine metabolism, selenoamino acid metabolism, and aminoacyl-trna biosynthesis.
Specifications
MARS2 | |
Polyclonal | |
Unconjugated | |
MARS2 | |
C730026E21Rik; COXPD25; EC 6.1.1.10; MARS2; methionine tRNA ligase 2, mitochondrial; methionine--tRNA ligase 2; methionine--tRNA ligase, mitochondrial; methionine-tRNA synthetase 2 (mitochondrial); methionine-tRNA synthetase 2, mitochondrial; methionyl-tRNA synthetase 2; methionyl-tRNA synthetase 2, mitochondrial; methionyl-tRNA synthetase, mitochondrial; MetRS; mitochondrial methionine--tRNA ligase; mitochondrial methionyl-tRNA synthetase; mtMetRS; RGD1311527 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
92935 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96GW9 | |
MARS2 | |
Recombinant protein corresponding to Human MARS2. Recombinant protein control fragment (Product #RP-96143). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction